BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21225217)

  • 1. Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association.
    Antonello VS; Appel da Silva MC; Cambruzzi E; Kliemann DA; Santos BR; Queiroz-Telles F
    Rev Inst Med Trop Sao Paulo; 2010; 52(6):329-31. PubMed ID: 21225217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
    Park SG; Oh SH; Suh SB; Lee KH; Chung KY
    Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Successful Treatment of Chromoblastomycosis Caused by
    Bao F; Wang Q; Yu C; Shang P; Sun L; Zhou G; Wu M; Zhang F
    Am J Trop Med Hyg; 2018 Jul; 99(1):124-126. PubMed ID: 29785921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyphellophora laciniata: A new etiological agent of chromoblastomycosis.
    León-Lara X; Atoche C; Arenas R; Martínez-Hernández F; Martínez-Chavarría LC; Xicohtencatl-Cortes J; Vázquez-Aceituno VA; Hernández-Castro R
    J Mycol Med; 2022 Mar; 32(1):101204. PubMed ID: 34598111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases.
    Belda W; Criado PR; Domingues Passero LF
    Am J Trop Med Hyg; 2020 Nov; 103(5):1852-1854. PubMed ID: 32815507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromoblastomycosis: an exuberant case.
    Gomes NM; Bastos TC; Cruz KS; Francesconi F
    An Bras Dermatol; 2014; 89(2):351-2. PubMed ID: 24770521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromoblastomycosis in a resident of a leprosarium.
    Dashatwar D; Kar S; Gangane N; Pol V; Madke B; Kulkarni S; Singh N
    Lepr Rev; 2015 Mar; 86(1):102-7. PubMed ID: 26065153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromoblastomycosis imported from Malta.
    Ezughah FI; Orpin S; Finch TM; Colloby PS
    Clin Exp Dermatol; 2003 Sep; 28(5):486-7. PubMed ID: 12950332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of chromoblastomycosis responding to treatment with itraconazole.
    Smith CH; Barker JN; Hay RJ
    Br J Dermatol; 1993 Apr; 128(4):436-9. PubMed ID: 8388236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chromoblastomycosis.
    Pradinaud R; Bolzinger T
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):869-70. PubMed ID: 1666399
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphangitic chromoblastomycosis.
    Muhammed K; Nandakumar G; Asokan KK; Vimi P
    Indian J Dermatol Venereol Leprol; 2006; 72(6):443-5. PubMed ID: 17179621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromoblastomycosis: clinical experience and review of literature.
    Queiróz AJR; Pereira Domingos F; Antônio JR
    Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa.
    Arango M; Jaramillo C; Cortés A; Restrepo A
    Med Mycol; 1998 Feb; 36(1):43-5. PubMed ID: 9776811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy.
    Zheng J; Liu S; Xie Z; Chen Y; Xi L; Liu H; Liu Y
    Ann Clin Microbiol Antimicrob; 2024 Jun; 23(1):57. PubMed ID: 38902740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromomycosis acquired in a non-tropical area: A case report].
    Ouédraogo MS; Vignon-Pennamen MD; Battistella M; Levy A; Feuilhade de Chauvin M; Petit A
    Ann Dermatol Venereol; 2017; 144(6-7):438-442. PubMed ID: 28396061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis.
    Azevedo Cde M; Marques SG; Resende MA; Gonçalves AG; Santos DV; da Silva RR; de Sousa Mda G; de Almeida SR
    Mycoses; 2008 Jul; 51(4):341-4. PubMed ID: 18444974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.